CAS No.: 709031-78-7
盐酸沙格列汀 Catalog No. CSN24704
Synonyms: BMS-477118 hydrochloride;BMS-477118 HCl;Saxagliptin HCl
Saxagliptin, also known as BMS-477118, is a new oral hypoglycemic (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Saxagliptin was approved in 2008 for the treatment of type 2 diabetes. Saxagliptin is a competitive DPP4 inhibitor that slows the inactivation of the incretin hormones, thereby increasing their bloodstream concentrations and reducing fasting and postprandial glucose concentrations in a glucose-dependent manner in patients with type 2 diabetes mellitus. .
| 规格 | 价格 | 促销价格 | 库存 | 数量 |
|---|
400-920-2911
sales@csnpharm.cn
tech@csnpharm.cn
纯度 & 质量文件
批次:
靶点选择性
生物活性
实验方案
- 计算器
- 储存液制备
技术信息
| CAS号 | 709031-78-7 | 储存条件 |
|
|
| 分子式 | C18H26ClN3O2 | 运输 | 蓝冰 | |
| 分子量 | 351.87 | 别名 | BMS-477118 hydrochloride;BMS-477118 HCl;Saxagliptin HCl;Saxagliptin (hydrochloride);BMS-477118;Saxagliptin;brand name: Onglyza |
